Beyond the Ivory Tower: Outcomes Following Surgery for Ampullary Cancer Andrew M. Lowy Hepatic and Pancreatic Tumors Open access 19 April 2008 Pages: 1813 - 1814
Is Lymphatic Mapping in Uterine Cancer Feasible? Michael FrumovitzCharles F. Levenback Gynecologic Oncology 13 May 2008 Pages: 1815 - 1817
Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All Lisa A. NewmanNathalie Kim RoffArmin D. Weinberg Healthcare Policy and Outcomes Open access 19 April 2008 Pages: 1818 - 1819
Survival After Resection of Ampullary Carcinoma: A National Population-Based Study Jessica B. O’ConnellMelinda A. MaggardO. Joe Hines Healthcare Policy and Outcomes 28 March 2008 Pages: 1820 - 1827
Urban/Rural Residence Moderates Effect of Race on Receipt of Surgery in Patients with Nonmetastatic Breast Cancer: A Report from the South Carolina Central Cancer Registry N. F. EsnaolaK. KnottM. E. Ford Healthcare Policy and Outcomes 09 April 2008 Pages: 1828 - 1836
Certificate of Need Regulations and the Availability and Use of Cancer Resections Marah N. ShortThomas A. AloiaVivian Ho Healthcare Policy and Outcomes 06 May 2008 Pages: 1837 - 1845
Health-Related Quality of Life Outcomes in Disease-Free Survivors of Mid-Low Rectal Cancer After Curative Surgery Salvatore PucciarelliPaola Del BiancoDonato Nitti Healthcare Policy and Outcomes 06 May 2008 Pages: 1846 - 1854
Angiography is Indicated for Every Sentinel Bleed after Pancreaticoduodenectomy Yu-Wen TienYao-Ming WuPo-Huang Lee Hepatic and Pancreatic Tumors 16 April 2008 Pages: 1855 - 1861
Intraoperative Radiofrequency Ablation for Hepatocellular Carcinoma: Long-Term Results in a Large Series Young-sun KimHyunchul RhimSung Joo Kim Hepatic and Pancreatic Tumors 08 May 2008 Pages: 1862 - 1870
A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals Unal AydinSuleyman YedibelaAhmet Coker Hepatic and Pancreatic Tumors 03 May 2008 Pages: 1871 - 1879
Intrahepatic Cholangiocarcinoma and Combined Hepatocellular-Cholangiocarcinoma: A Western Experience Nazario PortolaniGian Luca BaiocchiStefano Maria Giulini Hepatic and Pancreatic Tumors 29 April 2008 Pages: 1880 - 1890
Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases Liselot B. J. van IerselEllen J. HoekmanCornelis J. H. van de Velde Gastrointestinal Oncology Open access 10 May 2008 Pages: 1891 - 1898
Portal Vein Segmentation of a 3D-Planning System for Liver Surgery—In vivo Evaluation in a Porcine Model Kai S. LehmannJoerg-P. RitzBernd B. Frericks Hepatic and Pancreatic Tumors 01 May 2008 Pages: 1899 - 1907
Major Hepatectomy for Colorectal Metastases: Is Preoperative Portal Occlusion an Oncological Risk Factor? L. MuellerC. HillertD. C. Broering Hepatic and Pancreatic Tumors 06 May 2008 Pages: 1908 - 1917
Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer Hyeong-Gon MoonYoung-Tae JuSang-Kyung Choi Gastrointestinal Oncology 05 April 2008 Pages: 1918 - 1922
Predictors of Multivisceral Resection in Patients with Locally Advanced Colorectal Cancer Anand GovindarajanNovlette FraserAnna R. Gagliardi Gastrointestinal Oncology 13 May 2008 Pages: 1923 - 1930
Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer A. S. CaudleH. J. KimM. O. Meyers Gastrointestinal Oncology 17 April 2008 Pages: 1931 - 1936
Radical Resection After IORT-Containing Multimodality Treatment is the Most Important Determinant for Outcome in Patients Treated for Locally Recurrent Rectal Cancer Raphaëla C. DresenMarleen J. GosensHarm J. Rutten Gastrointestinal Oncology Open access 04 April 2008 Pages: 1937 - 1947
Squamous Cell Carcinoma of the Anal Canal: Utilization and Outcomes of Recommended Treatment in the United States Karl Y. BilimoriaDavid J. BentremAmy L. Halverson Gastrointestinal Oncology 15 April 2008 Pages: 1948 - 1958
Tumor Diameter as a Prognostic Factor in Patients with Gastric Cancer Chikara KunisakiHirochika MakinoHiroshi Shimada Gastrointestinal Oncology 28 March 2008 Pages: 1959 - 1967
The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma Young Soo ParkMin Young JinSe Jin Jang Gastrointestinal Oncology 10 May 2008 Pages: 1968 - 1976
Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor Masahiko KoikeYasuhiro KoderaAkimasa Nakao Gastrointestinal Oncology 12 April 2008 Pages: 1977 - 1982
Poor Hormone Receptor Expression in East African Breast Cancer: Evidence of a Biologically Different Disease? P. A. BirdA. G. HillN. Houssami Breast Oncology 12 April 2008 Pages: 1983 - 1988
Genomic Alterations Associated with Early Stages of Breast Tumor Metastasis Rachel E. EllsworthDarrell L. EllsworthCraig D. Shriver Breast Oncology 10 April 2008 Pages: 1989 - 1995
Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer Rebecca Crane-OkadaRobert A. WascherArmando E. Giuliano Breast Oncology 16 April 2008 Pages: 1996 - 2005
A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer Kimberly A. VanderveenRajendra RamsamoojRichard J. Bold Breast Oncology 15 May 2008 Pages: 2006 - 2011
Comparison of Laparoscopy and Laparotomy in Surgical Staging of Early-Stage Ovarian and Fallopian Tubal Cancer Jeong-Yeol ParkDae-Yeon KimJoo-Hyun Nam Gynecologic Oncology 25 April 2008 Pages: 2012 - 2019
Extent of Prophylactic Lymph Node Dissection in the Central Neck Area of the Patients with Papillary Thyroid Carcinoma: Comparison of Limited Versus Comprehensive Lymph Node Dissection in a 2-Year Safety Study Young-Ik SonHan-Sin JeongJeesun Choi Endocrine Tumors 06 May 2008 Pages: 2020 - 2026
The Functional Impact on Voice of Sternothyroid Muscle Division During Thyroidectomy Leonard R. HenryNancy Pearl SolomonAlexander Stojadinovic Endocrine Tumors 06 May 2008 Pages: 2027 - 2033
A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma Heather B. NeumanAmi PatelDaniel G. Coit Melanomas 09 May 2008 Pages: 2034 - 2041
Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis Marganit BenishInbal BartalShamgar Ben-Eliyahu Gastrointestinal Oncology 09 April 2008 Pages: 2042 - 2052
Lesions of “Uncertain Malignant Potential” Diagnosed by Vacuum-Assisted Breast Biopsy: An Unclear Management? George ZografosFlora ZagouriEffstratios Patsouris Breast Oncology 19 April 2008 Pages: 2053 - 2054
Management of B3 Lesions and Breast Biopsies Mary F. DillonEnda W. Mc DermottCecily M. Quinn Breast Oncology 07 May 2008 Pages: 2055 - 2056
Inhibition of Proliferation to Omega-3 Fatty Acids in Chemoresistant Pancreatic Cancer Cells: Mechanism of Action May be More Complex Raj Persaud Hepatic and Pancreatic Tumors 20 March 2008 Pages: 2057 - 2057
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer Sabrina IrmscherNorbert SenningerChristina Schleicher Medical Oncology 12 February 2008 Pages: 2059 - 2060
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer Daniel H. PalmerDeborah D. StockenSimon R. Bramhall Hepatic and Pancreatic Tumors 10 May 2008 Pages: 2061 - 2061
Can Intraoperative Intraperitoneal Free Cancer Cell Detection Techniques Identify Patients at Higher Recurrence Risk Following Curative Colorectal Cancer Resection? A Meta-Analysis Mesut Tez Hepatic and Pancreatic Tumors 14 March 2008 Pages: 2062 - 2062
A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases? V. E. de MeijerJ. N. M. IJzermansC. Verhoef Gastrointestinal Oncology Open access 08 March 2008 Pages: 2063 - 2063
A Place for Radiofrequency Ablation in the Treatment of Resectable Colorectal Liver Metastases? Stefaan MulierTheo RuersYicheng Ni Gastrointestinal Oncology 10 May 2008 Pages: 2064 - 2065
Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor Hamid Namazi Bone and Soft Tissue Sarcomas 29 December 2007 Pages: 2066 - 2067